| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |